Regorafenib: FDA Approved medicine

Anniepery21 Jan, 2022Health

The drug Regorafenib was approved by FDA in 2012 for the treatment of patients who have metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is a small molecule inhibitor of multiple membrane-bound and intracellular kinases involved in normal cellular functions and pathologic processes such as oncogenesis, tumour angiogenesis, metastasis, and tumour immunity. This medicine is supplied in 40 mg tablets for oral administration. Regorafenib 40 mg price in India is affordable, and one can purchase this medicine from any generic medicine supplier. The Indian Pharma is one of the best generic medicine suppliers worldwide, supplying for more than 7 years.